Literature DB >> 342255

Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264--137) in advanced human cancers.

P Juret, A Tanguy, A Girard, J Y Le Talaer, J S Abbatucci, N Dat-Xuong, J B Le Pecq, C Paoletti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 342255     DOI： 10.1016/0014-2964(78)90180-9

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  Sequence-selective binding of an ellipticine derivative to DNA.

Authors:  C Bailly; C OhUigin; C Rivalle; E Bisagni; J P Hénichart; M J Waring
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

Review 2.  Applications of Friedel-Crafts reactions in total synthesis of natural products.

Authors:  Majid M Heravi; Vahideh Zadsirjan; Pegah Saedi; Tayebeh Momeni
Journal:  RSC Adv       Date:  2018-12-03       Impact factor: 4.036

3.  Cardiac and vascular effects of elliptinium in guinea pigs. Involvement of a histaminergic mechanism.

Authors:  A Eschalier; J Lavarenne; M Renoux; P Tounissou
Journal:  Agents Actions       Date:  1985-07

4.  Regioselective arylation of ribose in adenosine and guanosine with the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.

Authors:  J Bernadou; B Meunier; G Meunier; C Auclair; C Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

5.  Bronchopulmonary effects of elliptinium in anesthetized dogs.

Authors:  A Eschalier; J Lavarenne; M Renoux
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

6.  A novel structural derivative of natural alkaloid ellipticine, MDPSQ, induces necrosis in leukemic cells.

Authors:  M S Shahabuddin; Mridula Nambiar; Balaji T Moorthy; Prakruthi L Naik; Bibha Choudhary; Gopal M Advirao; Sathees C Raghavan
Journal:  Invest New Drugs       Date:  2010-01-13       Impact factor: 3.850

7.  Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptinium.

Authors:  G E Umbach; V Hug; G Spitzer; H Thames; B Drewinko
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.